Nicholas DeVito
Biographic Data
| ID | 7703592 |
|---|---|
| NAME | Nicholas DeVito |
| GIVEN NAMES | Nicholas |
| FAMILY NAME | DeVito |
| SIGNATURE | DEVITO N |
| AFFILIATIONS | University of Oxford |
| ORCID | 0000-0001-8286-1995 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Barriers and best practices to improving clinical trials transparency at UK public research institutions
OBJECTIVES: Since 2017, the UK government has made concerted efforts to ensure the dissemination of clinical trials conducted at public research institutions. This study aims to understand how stakeholders within these institutions responded to these pressures and modified internal policies and processes while identifying best practices and barriers to improved transparency practice. METHODS: Research governance and trial management staff from UK…
Ethnic differences in Sars-CoV-2 infection and Covid-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
BACKGROUND: COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England. METHODS: We conducted an observational cohort study of adults (aged ≥18 years) registered with primary care practices in England for whom electronic health records were available through the OpenSAF…
E-cigarette manufacturers’ compliance with clinical trial reporting expectations
Our findings raise substantial concerns regarding these trials. Clinicians, public health professionals, and the public cannot make informed choices about the benefits or hazards of e-cigarettes if the results of clinical trials are not completely and transparently reported. Clarification and potential enforcement of reporting laws may be required
No prominent works on this page.
Ethnic differences in Sars-CoV-2 infection and Covid-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
BACKGROUND: COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England. METHODS: We conducted an observational cohort study of adults (aged ≥18 years) registered with primary care practices in England for whom electronic health records were available through the OpenSAF…
E-cigarette manufacturers’ compliance with clinical trial reporting expectations
Our findings raise substantial concerns regarding these trials. Clinicians, public health professionals, and the public cannot make informed choices about the benefits or hazards of e-cigarettes if the results of clinical trials are not completely and transparently reported. Clarification and potential enforcement of reporting laws may be required
Barriers and best practices to improving clinical trials transparency at UK public research institutions
OBJECTIVES: Since 2017, the UK government has made concerted efforts to ensure the dissemination of clinical trials conducted at public research institutions. This study aims to understand how stakeholders within these institutions responded to these pressures and modified internal policies and processes while identifying best practices and barriers to improved transparency practice. METHODS: Research governance and trial management staff from UK…
Medicine (3 works) · Ethics in Clinical Research (2 works) · Meta-analysis and systematic reviews (2 works) · Pharmaceutical industry and healthcare (2 works) · 2019-20 coronavirus outbreak (1 work) · Accountability (1 work) · Alternative medicine (1 work) · Best practice (1 work) · Business (1 work) · Clinical trial (1 work)